Bodhi Tree Biotechnology Inc (BDTB)
About Bodhi Tree Biotechnology Inc
BODHI TREE BIOTECHNOLOGY
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $17.0K
- Net income
- -$149.7K
- Total assets
- $119.2K
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Bodhi Tree Biotechnology Inc (BDTB) Stock Price
- Reported a net loss of $149.7K in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Bodhi Tree Biotechnology Inc.
Write a review
Bodhi Tree Biotechnology Inc: frequently asked questions
Is Bodhi Tree Biotechnology Inc an American company?
Bodhi Tree Biotechnology Inc is a US-based company headquartered in Danville, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bodhi Tree Biotechnology Inc headquartered?
Bodhi Tree Biotechnology Inc is headquartered in Danville, California, United States.
Is Bodhi Tree Biotechnology Inc publicly traded?
Yes — Bodhi Tree Biotechnology Inc is a publicly traded company. Its stock trades under the ticker symbol BDTB on the OTC.
What does Bodhi Tree Biotechnology Inc do?
Bodhi Tree Biotechnology Inc is an American Professional Services company in the Business & Financial Services sector.
